Project/Area Number |
16H06759
|
Research Category |
Grant-in-Aid for Research Activity Start-up
|
Allocation Type | Single-year Grants |
Research Field |
Otorhinolaryngology
|
Research Institution | The University of Tokyo |
Principal Investigator |
Akashi Ken 東京大学, 医学部附属病院, 助教 (90779331)
|
Research Collaborator |
YAMASOBA Tatsuya
ANDO Mizuo
YOSHIDA Masafumi
SAITO Yuki
FUKUOKA Osamu
MURAKAMI Yoshinori
|
Project Period (FY) |
2016-08-26 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 血中循環腫瘍DNA / デジタルPCR / 頭頸部癌 / EBV関連上咽頭癌 / HPV関連中咽頭癌 / ctDNA / 頭頸部がん / バイオマーカー / ctDNA / ctDNA / HPV関連中咽頭がん / EBV関連上咽頭がん |
Outline of Final Research Achievements |
The objective of this study was to examine whether ctDNA of virus-related head and neck cancer could be detected using droplet digital polymerase chain reaction (PCR), which enables quantification of nucleic acids with a higher accuracy, sensitivity, and precision than traditional real-time PCR. We collected plasma from blood samples of 4 patients with EBV-related nasopharyngeal cancer and 18 patients with HPV-related oropharyngeal cancer. We extracted cell-free DNA from the plasma and detected ctDNA using droplet digital PCR targeting base sequences of EBV-DNA and HPV-DNA integrated into the DNA of cancer cells. We successfully detected ctDNA in the blood of 3 patients (75%) with EBV-related nasopharyngeal cancer and 10 patients (56%) with HPV-related oropharyngeal cancer.
|